March 10, 2011 – The U.S. Food and Drug Administration (FDA) has granted an abbreviated new drug application (ANDA) for a fludeoxyglucose (FDG) F18 injection. Siemens PETNet Solutions is the first commercial manufacturer and distributor to achieve approval of an ANDA for F18 FDG.

March 10, 2011 – The first study to compare pain associated with deployment of different vascular closure devices (VCD) as the primary endpoint has been published in the Journal of NeuroInterventional Surgery. The trial compared the discomfort associated with the Mynx 5 French VCD, from AccessClosure, to the Angio-Seal Evolution Device.

March 10, 2011 – New guidelines have been published in The Annals of Thoracic Surgery that include point-of-care testing for platelet reactivity as a new recommendation for preoperative patient assessment.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now